MedPath

ORGANON PHARMA (UK) LIMITED

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

47

Active:43
Completed:2

Trial Phases

2 Phases

Phase 1:17
Phase 3:4

Drug Approvals

82

EMC:42
NMPA:20
SFDA:20

Drug Approvals

Finasteride Tablets

Product Name
保法止
Approval Number
国药准字HJ20160326
Approval Date
Nov 7, 2024
NMPA

Finasteride Tablets

Product Name
保法止
Approval Number
国药准字HJ20160325
Approval Date
Nov 7, 2024
NMPA

Finasteride Tablets

Product Name
保列治
Approval Number
国药准字HJ20160290
Approval Date
Nov 4, 2024
NMPA

Finasteride Tablets

Product Name
保列治
Approval Number
国药准字HJ20160291
Approval Date
Nov 4, 2024
NMPA

Losartan Potassium Tablets

Product Name
科素亚
Approval Number
国药准字HJ20202003
Approval Date
Jul 3, 2023
NMPA

Losartan Potassium Tablets

Product Name
科素亚
Approval Number
国药准字HJ20171245
Approval Date
Apr 21, 2022
NMPA

Losartan Potassium Tablets

Product Name
科素亚
Approval Number
国药准字HJ20171246
Approval Date
Apr 21, 2022
NMPA

Losartan Potassium Tablets

Product Name
氯沙坦钾片
Approval Number
国药准字HJ20171081
Approval Date
Dec 14, 2021
NMPA

Losartan Potassium Tablets

Product Name
氯沙坦钾片
Approval Number
国药准字HJ20171083
Approval Date
Dec 14, 2021
NMPA

Losartan Potassium Tablets

Product Name
氯沙坦钾片
Approval Number
国药准字HJ20171082
Approval Date
Dec 14, 2021
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (21 trials with phase data)• Click on a phase to view related trials

Phase 1
17 (81.0%)
Phase 3
4 (19.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.